Selda Murat

Comparison of pan‐immune‐inflammation value with other inflammation markers of long‐term survival after<scp>ST</scp>‐segment elevation myocardial infarction

Selda Murat, Mehmet Özgeyik, Muzaffer Bilgin · European Journal of Clinical Investigation · 2022 · 145 citations · Full text

Medicine, Cardiology, Immunology +17

Trends in heart failure between 2016 and 2022 in Türkiye (TRends-HF): a nationwide retrospective cohort study of 85 million individuals across entire population of all ages

Ahmet Çelik, Dilek Ural, Tuğçe Çöllüoğlu et al. · The Lancet Regional Health - Europe · 2023 · 29 citations · Full text

Public Health, Cardiology, Health Sciences +17

Impact of COVID-19 outbreak on patients with ST-segment elevation myocardial ınfarction (STEMI) in Turkey: results from TURSER study (TURKISH St-segment elevation myocardial ınfarction registry)

Tuba Ekin, Didar Elif Akgün, Arafat Yidirim et al. · Journal of Thrombosis and Thrombolysis · 2021 · 20 citations · Full text

Medicine, Cardiology, Internal Medicine +13

Real-World Data on Empagliflozin and Dapagliflozin Use in Patients with HEART Failure: The RED–HEART Study

Umut Kocabaş, Veysel Yavuz, Cihan Altın et al. · ESC Heart Failure · 2024 · 20 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Prognostic Value of D-Dimer/Fibrinogen Ratio on In-Hospital Outcomes of Patients With Heart Failure and Covid-19

Selda Murat, Muhammet Dural, Gurbet Özge Mert et al. · Biomarkers in Medicine · 2021 · 13 citations · Full text

Medicine, Cardiology, Internal Medicine +11